Passport Health Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2006
NCT00395174
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Passport Health Maryland | Passport Health New Jersey

Active Ingredients

Drugs in Phase 3 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1